Drug | Liraglutide | Exenatide | ||||||
Year | 2011 (4 months) | 2012 | 2011 (4 months) | 2012 | ||||
Days of treatment | ||||||||
Mediane | 94 | 210 | 115 | 268 | ||||
Range | 20 | 120 | 19 | 365 | 30 | 120 | 30 | 365 |
WRDD | ||||||||
Average ± DS | 1.30 ± 0.46 | 1.27 ± 0.38 | 16.62 ± 4.74 | 17.56 ± 5.00 | ||||
WPDD | ||||||||
Average ± DS | 1.40 ± 0.27 | 1.37 ± 0.27 | 19.38 ± 1.68 | 19.60 ± 1.34 | ||||
WADH | ||||||||
Average ± DS | 0.93 ± 0.29 | 0.94 ± 0.27 | 0.87 ± 0.30 | 0.90 ± 0.27 | ||||